Chinese medical devices manufacturer Mindray has introduced new defibrillation solutions, the BeneHeart D60 and D30, to raise the standards for resuscitation.

The next-generation BeneHeart defibrillators offer reliability, expert diagnosis and monitoring tools to launch a whole-process quality improvement solution for in-hospital and pre-hospital rescue.

They include upgrades that elevate the ease of use, as well as the reliability of the devices.

BeneHeart D60 and D30 feature high-definition capacitive large screen buttons for crucial operations as well as physical knobs. The defibrillators weigh 4.2kg with the battery.

The screen supports simple gesture control for increased operational efficiency.

The drop-protection design of the BeneHeart D60 and D30 also features water and dust proofing and can operate in temperatures from -20°C to 55°C.

They provide a complete CPR evaluation system to monitor the real-time performance of CPR and provide clinicians with instant feedback.

The two new BeneHeart defibrillators also include QShock and filtered electrocardiogram (ECG) analysis technologies, which help lessen the interruption and charging times for faster defibrillation.

Mindray International PMLS sales and marketing general manager Mark Sun said: “Defibrillators play a critical role in reducing all-cause mortality and emergencies.

“We believe that through upgrading first-aid diagnosis and treatment tools and introducing comprehensive rescue quality improvement schemes, we can ensure that prompt, correct and high-quality medical interventions are implemented to save patients’ lives and improve their quality of life.”

Both BeneHeart D60 and D30 comprise structured debriefing protocols that help in automatically recording and uploading rescue data.

This helps to improve the future performance of resuscitation teams.

With intelligent assistance, the new BeneHeart D60 provides professional 12-lead ECG analysis functions, which help to efficiently diagnose chest pain conditions, as well as identify myocardial infarction locations.

It also includes a six-channel recorder that produces real-time ECG reports.

The diagnosis reports can be sent to a target hospital remotely, allowing them to plan advanced treatment for critically ill patients.